PLoS launches new collection on control, elimination of human helminthiases

NewsGuard 100/100 Score
Apr 26 2012

"The April 2012 issue of PLoS Neglected Tropical Diseases features the launch of a new collection, 'A research agenda for the control and elimination of human helminthiases,'" the PLoS "Speaking of Medicine" blog reports. According to the blog, "The collection includes a series of eight reviews from the Disease Reference Group on Helminth Infections (DRG4) that, taken together, outline a research and development (R&D) agenda for the control and elimination of helminth diseases of humans" (4/24).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Medical Research News | Disease/Infection News

    Tags: , , ,

    Comments (0)

    Suggested Reading

    Expanding research and clinical options for children with cancer
    Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies
    New research sheds light on how GLP-1 obesity drugs may change food cravings
    Research finds link between unhealthy eating and chronic pain severity, calls for comprehensive dietary support
    Increased emotional sensitivity linked to previous COVID-19 infection, new research suggests
    Neurological Narratives: A Journey into Women's Brain Health Research
    Rising antibiotic resistance prompts shift to ecological research strategies in infection control
    Do you wear makeup while you exercise? New research reveals the effects on skin and pores

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis